Avanos Medical (AVNS) Cash from Operations (2013 - 2026)

Avanos Medical has disclosed Cash from Operations across 14 years of filings, most recently posting 12300000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 12300000.0, down 147.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 36700000.0 (down 72.69% YoY), and the FY2025 annual result was 74700000.0, down 25.82% from the prior year.
• Cash from Operations came in at 12300000.0 for Q1 2026 at Avanos Medical, down from 28200000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 57900000.0 in Q4 2024 to a low of 12300000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 23000000.0 (2024), against an average of 16847058.82.
• Across the five-year window, Cash from Operations plunged 477.78% in 2023 and surged 1169.23% in 2024, its largest moves.
• Avanos Medical's Cash from Operations stood at 33700000.0 in 2022, then sank by 62.31% to 12700000.0 in 2023, then surged by 355.91% to 57900000.0 in 2024, then plunged by 51.3% to 28200000.0 in 2025, then slumped by 143.62% to 12300000.0 in 2026.
• The last three Cash from Operations figures came in at 12300000.0 (Q1 2026), 28200000.0 (Q4 2025), and 14000000.0 (Q3 2025), per Business Quant data.